This report contains market size and forecasts of Bumetanide in global, including the following market information:
Global Bumetanide Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Bumetanide Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Bumetanide companies in 2021 (%)
The global Bumetanide market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bumetanide include Pfizer, Teva, Zydus Pharmaceuticals, Validus Pharmaceuticals, Upsher-Smith, Guilin Nanyao Company, Eisai, Liaoning Yuhuang Pharmaceutical and Amneal and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bumetanide manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bumetanide Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bumetanide Market Segment Percentages, by Type, 2021 (%)
Oral Drugs
Injection Drugs
Global Bumetanide Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bumetanide Market Segment Percentages, by Application, 2021 (%)
Hospital
Drug Store
Global Bumetanide Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bumetanide Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bumetanide revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Bumetanide revenues share in global market, 2021 (%)
Key companies Bumetanide sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Bumetanide sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Teva
Zydus Pharmaceuticals
Validus Pharmaceuticals
Upsher-Smith
Guilin Nanyao Company
Eisai
Liaoning Yuhuang Pharmaceutical
Amneal
Sandoz